Thermal Imaging was approved in 1982 by the FDA (Food and Drug Administration) in USA as an adjunctive risk assessment tool for the detection of breast cancer.

The applications of ThermaVUE® Medical Thermal Imaging are broad and range from the early detection of breast cancer to peripheral and extra cranial cerebral and facial vascular disease, metabolic disorders like diabetes, thyroid gland abnormalities, neuromusculoskeletal disorders such as repetitive strain injuries like carpel tunnel syndrome, pain trigger points, sports and soft tissue injuries, hormone imbalances in the breast, dermatological disorders and various inflammatory conditions like arthritis, gout and dental abscesses to mention just a few ( please see the extensive list below)

It is important to note that thermal imaging (also known as infrared imaging, thermography or thermology), like other imaging procedures (e.g. CT, MRI, mammography, ultrasound) does not provide a diagnosis. Only your physician can provide you with a diagnosis.

What most of us are accustomed to when we think of medical imaging is the use of X-ray, CT, MRI, or ultrasound. All of these imaging tools are considered structural imaging technologies – they look inside the body for structural changes such as broken bones, tumours, damage to organs, etc. What separates these technologies from infrared imaging is that Thermal Imaging detects infrared (heat) markers that reflect the body’s subtle underlying chemical and nervous system signals. This allows us to look at how the body is functioning.

Thermography is a safe and effective means to help in the diagnosis of:

  • Altered gait manifestations
  • Arteriosclerosis (peripheral)
  • Arthritis
  • Brachial Plexus Injury
  • Breast Disease / Breast Cancer
  • Bursitis
  • Carotid Artery Stenosis
  • Carpal Tunnel Syndrome
  • Chronic pain
  • Compartment Syndromes
  • Complex Regional Pain Syndrome (CRPS)
  • Dental Irritation/Inflammation
  • Diabetes (secondary complications)
  • Disc Syndromes (spinal discogenic pain)
  • Facet Syndrome
  • Fibromyalgia
  • Headache Evaluation (e.g. cervicogenic, migraine, sinus)
  • Herniated Disc/Ruptured Disc
  • Hypesthesia
  • Hyperaesthesia
  • Inflammation
  • Intervertebral Disc Disease
  • Ligament Tears
  • Lumbosacral Plexus Injury
  • Metabolic Conditions
  • Muscular Spasm
  • Muscle Tears
  • Myofascial Irritation
  • Myofascial Pain Syndrome
  • Neck and Back Problems
  • Nerve Entrapment
  • Nerve Impingement/Pressure
  • Nerve Root Irritation
  • Nerve Stretch Injury
  • Nervous System Disorders
  • Neuritis
  • Neuropathy
  • Neurovascular Compression
  • Osteoarthritis
  • Pain Syndromes
  • Paresthesia
  • Peripheral Nerve Abnormalities
  • Pinched Nerves
  • Referred Pain Syndromes
  • Reflex Sympathetic Dystrophy (RSD)
  • Repetitive Strain Injuries
  • Raynaud’s Disease
  • Rheumatoid Arthritis
  • Sacroiliac Ligament Tear
  • Sacroiliac Syndrome
  • Sensory Nerve Abnormalities
  • Sinus Irritation/Inflammation
  • Skin Conditions
  • Soft Tissue Injury
  • Spinal Cord Injury
  • Sports Injuries
  • Strain/Sprains
  • Stroke Risk
  • Superficial Vascular Disease
  • Synovitis
  • Temporal Arteritis
  • Tendonitis
  • Thoracic Outlet Syndrome
  • Thyroid Conditions
  • TMJ Dysfunction (TMD)
  • Trigeminal Neuralgia
  • Trigger Points
  • Vascular Disorders
  • Whiplash Conditions
  • And many more … (10)

ThermaVUE® Medical Thermal Imaging is

  • 100% safe
  • Non-invasive, no contact
  • No pain,
  • No compression
  • No radiation
  • Accuracy – no false positives
  • Suitable for everyone of any age
  • Suitable for women with a pacemaker, dense breasts, implants, those who have undergone surgery and those who fall outside of routine mammograms analysis
  • Allows for more frequent imaging to monitor changes and / or healing as a result of treatment and or lifestyle choices (including HRT and removal of Soy and other phytoestrogens from the diet).
  • Quick and simple

However, as noted above, Medical Thermal Imaging is a physiological test, it does not have the ability to pinpoint the location or size of a tumour nor can it detect 100% of all cancers. Consequently, Thermal Imaging’s role is in addition (as an adjunct) to structural imaging like mammography, ultrasound, MRI and physical examination, not in lieu of.

Experts have concluded that no one procedure or method of imaging is solely adequate for breast cancer screening (1,2,6). Studies show there is an increase in survival rate when breast self-exams, physician exams, breast thermography and structural imaging like mammography, ultrasound and MRI are used together in a multi-modal approach providing the earliest detection system available to date (3,7,8,9). If treated in the earliest stages, survival rates greater than 95% are possible (3,6).

This is particularly good news for all women who have concerns about their breast health.

Since it has been determined that 1 in 7 women will get breast cancer, we must use every means possible to detect cancers early when there is the greatest chance for survival.

Simply put, early detection saves lives. ThermaVUE® Medical Thermal Imaging is redefining the word ‘EARLY’ for a more proactive approach to health where ‘EARLY’ affords peace of mind or the time to make lifestyle changes – where ‘EARLY’ does not mean ‘just in time’ or sadly ‘too late’.

We look forward to being of service to you and your loved ones for the peace of mind or the information to follow up and act on the earliest markers to  protect and safeguard your health.

Thank you for taking a pro-active approach to your health and well-being and please share this important life-saving information with those you care about.

Best wishes for good health and happiness.


Angie Lacoste CTT

Founder & CEO

ThermaVUE® Medical Thermal Imaging

Breast and Body Thermal Imaging

Tel: 0333 772 7749


Redefining the ‘EARLY’ in ‘EARLY detection saves lives’!



REFERENCES (some courtesy

1.American Cancer Society – Breast Cancer Guidelines and Statistics, 2009-2010



  1. I. Nyirjesy, M.D. et al; Clinical Evaluation, Mammography and Thermography in the Diagnosis of Breast Carcinoma. Thermology, 1986; 1: 170-173.
    3. M. Gautherie, Ph.D.; Thermobiological Assessment of Benign and Malignant Breast Diseases. Am. J. Obstet. Gynecol., 1983; V 147, No. 8: 861-869.
    4. C. Gros, M.D., M. Gautherie, Ph.D.; Breast Thermography and Cancer Risk Prediction. Cancer, 1980; V 45, No. 1: 51-56.
    5. P. Haehnel, M.D., M. Gautherie, Ph.D. et al; Long-Term Assessment of Breast Cancer Risk by Thermal Imaging. In: Biomedical Thermology, 1980; 279-301.
    6. P. Gamigami, M.D.; Atlas of Mammography: New Early Signs in Breast Cancer. Blackwell Science, 1996.
    7. J. Keyserlingk, M.D.; Time to Reassess the Value of Infrared Breast Imaging? Oncology News Int., 1997; V 6, No. 9.
    8. P.Ahlgren, M.D., E. Yu, M.D., J. Keyserlingk, M.D.; Is it Time to Reassess the Value of Infrared Breast Imaging? Primary Care & Cancer (NCI), 1998; V 18, No. 2.
    9. N. Belliveau, M.D., J. Keyserlingk, M.D. et al ; Infrared Imaging of the Breast: Initial Reappraisal Using High-Resolution Digital Technology in 100 Successive Cases of Stage I and II Breast Cancer. Breast Journal, 1998; V 4, No. 4
  2. & Index Medicus – J Thermology, Acta Thermographica, J Breast